Alucent Biomedical Announces First Patient Enrolled in First In Human Natural Vascular Scaffolding Clinical Trial
Multicenter ACTIVATE II Study to Enroll up to 50 Patients in Australia SALT LAKE CITY--(BUSINESS WIRE)--Alucent Biomedical Inc. announced that...









